← Leaderboards
Louise G Cohen
Massachusetts General Hospital
$734,031
Attributed
$734,031
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$734,031 · 1
By mechanism
K08$734,031 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Donald C. Goff$14,005,830
- Nancy A Rigotti$18,154,837
- Schahram Akbarian$48,610,378
- Maurizio Fava$41,478,557
- David C Henderson$3,275,054
Others in their field
Top investigators on “Adolescence (12-20)”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$38,407,013
- Lloyd D Johnston · University Of Michigan At Ann Arbor$26,271,656
- Stephen A Spector · University Of California, San Diego$21,510,628
- Richard L Spoth · Iowa State University$19,460,648
- Craig M Wilson · University Of Alabama At Birmingham$18,374,977
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
Research focus
Adolescence (12-20)Antipsychotic AgentsBupropionClinical ResearchHuman SubjectHuman Therapy EvaluationMental Disorder ChemotherapyMiddle Childhood (6-11)ParoxetinePediatric PharmacologyPharmacokineticsPsychopharmacologySerotonin Inhibitor
Grant awards (5)
DEVELOPMENTAL PHARMCOKINETICS OF PSYCHORTOPIC DRUGS$152,492
K08 · FY2004 · MH
DEVELOPMENTAL PHARMCOKINETICS OF PSYCHORTOPIC DRUGS$149,623
K08 · FY2003 · MH
DEVELOPMENTAL PHARMCOKINETICS OF PSYCHORTOPIC DRUGS$146,838
K08 · FY2002 · MH
DEVELOPMENTAL PHARMCOKINETICS OF PSYCHORTOPIC DRUGS$144,134
K08 · FY2001 · MH
DEVELOPMENTAL PHARMACOKINETICS OF PSYCHOTROPIC DRUGS$140,944
K08 · FY2000 · MH